Pharmacogenetic factors determining the metabolism and safety of aromatic anticonvulsants in the residents of Russia

E. D. Spektor(Sechenov University), Д. А. Каштанова(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Anton А. Keskinov(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), A. M. Rumyantseva(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), V. S. Yudin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), А. А. Мамчур(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Ekaterina A. Snigir(Federal Agency for Health and Social Development), Sergey I. Mitrofanov(Center for Strategic Research), M. V. Ivanov(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), S. M. Yudin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency)
Extreme Medicine
November 20, 2025
Cited by 2


Related Papers